Yourgene Health PLC
LSE:YGEN
Yourgene Health PLC
Revenue
Yourgene Health PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yourgene Health PLC
LSE:YGEN
|
Revenue
£29.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
47%
|
CAGR 10-Years
94%
|
|
Smith & Nephew PLC
LSE:SN
|
Revenue
$5.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Revenue
$1.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Revenue
$254.5m
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Revenue
£52.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Creo Medical Group PLC
LSE:CREO
|
Revenue
£27.2m
|
CAGR 3-Years
1 163%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yourgene Health PLC's Revenue?
Revenue
29.7m
GBP
Based on the financial report for Sep 30, 2022, Yourgene Health PLC's Revenue amounts to 29.7m GBP.
What is Yourgene Health PLC's Revenue growth rate?
Revenue CAGR 10Y
94%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Yourgene Health PLC have been 33% over the past three years , 47% over the past five years , and 94% over the past ten years .